Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Kim

Showing results (21-30 of 207) with videos related to

Pageof 21
Sort By:
Clinical Advances in Hematology & Oncology : H&O|August 25, 2010
BRAF testing in advanced colorectal cancer: is it ready for prime time?Brooke Phillips, Matthew Kalady, Richard Kim
Anticancer Research|December 26, 2012
Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulatorSarah Beltrami, Richard Kim, Jennifer Gordon
Oncology|June 10, 2010
Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma?Ann Tan, Federico Aucejo, Richard Kim
The Lancet. Oncology|September 1, 2009
Is there a role for second-line chemotherapy in advanced gastric cancer?Robert Wesolowski, Chan Lee, Richard Kim
American Journal of Clinical Oncology|May 2, 2012
Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacyBassam Estfan, Michael Byrne, Richard Kim
The Oncologist|January 7, 2015
Locally advanced gastroesophageal junction tumor: a treatment dilemmaNoman Ashraf, Sarah Hoffe, Richard Kim
Oncotargets and Therapy|November 1, 2021
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of InfigratinibJames Yu, Amit Mahipal, Richard Kim
Liver International : Official Journal of the International Association for the Study of the Liver|October 20, 2011
General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?Masato Fujiki, Federico Aucejo, Richard Kim
The Oncologist|August 23, 2013
Adjuvant treatment for gastric cancer: chemotherapy versus radiationNoman Ashraf, Sarah Hoffe, Richard Kim
The Oncologist|April 15, 2014
French FNCLCC/FFCD 9703 studyNoman Ashraf, Sarah Hoffe, Richard Kim
Pageof 21

Showing results (21-30 of 207) with videos related to

Sort By:
Pageof 21
Clinical Advances in Hematology & Oncology : H&O|August 25, 2010
BRAF testing in advanced colorectal cancer: is it ready for prime time?Brooke Phillips, Matthew Kalady, Richard Kim
Anticancer Research|December 26, 2012
Neurofibromatosis type 2 protein, NF2: an uncoventional cell cycle regulatorSarah Beltrami, Richard Kim, Jennifer Gordon
Oncology|June 10, 2010
Is there a role for adjuvant treatment after hepatic resection for hepatocellular carcinoma?Ann Tan, Federico Aucejo, Richard Kim
The Lancet. Oncology|September 1, 2009
Is there a role for second-line chemotherapy in advanced gastric cancer?Robert Wesolowski, Chan Lee, Richard Kim
American Journal of Clinical Oncology|May 2, 2012
Sorafenib in advanced hepatocellular carcinoma: hypertension as a potential surrogate marker for efficacyBassam Estfan, Michael Byrne, Richard Kim
The Oncologist|January 7, 2015
Locally advanced gastroesophageal junction tumor: a treatment dilemmaNoman Ashraf, Sarah Hoffe, Richard Kim
Oncotargets and Therapy|November 1, 2021
Targeted Therapy for Advanced or Metastatic Cholangiocarcinoma: Focus on the Clinical Potential of InfigratinibJames Yu, Amit Mahipal, Richard Kim
Liver International : Official Journal of the International Association for the Study of the Liver|October 20, 2011
General overview of neo-adjuvant therapy for hepatocellular carcinoma before liver transplantation: necessity or option?Masato Fujiki, Federico Aucejo, Richard Kim
The Oncologist|August 23, 2013
Adjuvant treatment for gastric cancer: chemotherapy versus radiationNoman Ashraf, Sarah Hoffe, Richard Kim
The Oncologist|April 15, 2014
French FNCLCC/FFCD 9703 studyNoman Ashraf, Sarah Hoffe, Richard Kim
Pageof 21